Jean-Luc Devleeschauwer is currently President, Oncology Systems EMEIA & CIS for Varian Oncology Systems and a member of the Global Leadership team. Jean-Luc was President Asia Pacific for Varian Oncology Systems before moving back to Europe.
Prior to joining Varian, Jean-Luc was Vice President and General Manager, International, for nanoString, operating in the field of Genetic Testing with focus on a Breast Cancer signature. Jean-Luc has occupied for the last 27 years executive leadership positions with major global companies including Novartis Vaccines and Diagnostics, Siemens Healthcare Diagnostic and Dade Behring. His wealth of experience stems across the field of medical devices, diagnostic, pharma, blood banking, oncology, genetic testing and radiotherapy.
He has extensive multi-cultural management experience in Europe, USA and Asia, managing large operations, creating new structures or integrating organizations. Jean-Luc received both his DEUG (Diploma of General University Studies) in Business and Applied Economics and his Master’s Degree in Business and Finance from Paris IX Dauphine University, Paris, France.